ASHPOfficial

A review of RSV burden of disease, changes seen in the 2021 season, barriers to vaccine development, and summary of vaccine candidates currently in phase three clinical trial.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

As a special edition Patient Safety Awareness Week podcast, speakers discuss their work on the National Quality Forum’s Action Team on Person-Centered Medication Safety. The co-chairs of this Action Team highlight the priority challenges and recommendations for stakeholders to take away from this work. Additionally, they discuss creating meaningful partnerships with patients, families, and caregivers and outlining practical steps that hospitals and health systems can take to implement better person-centered medication safety.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode shares the experiences of pharmacists that went through the Phase II Match. Listeners will learn about their pharmacy school career goals, feelings on Phase I Match Day, and how they prepared and refocused to enter into the Phase II Match. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field on key issues for safe neuromuscular blockade and reversal. Discussion includes Intraoperative neuromuscular monitoring, dosing of reversal agents, and reversal strategies.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

From the 2021 Midyear Clinical Meeting, this featurette discusses the models of infusion services that health systems can provide, the implication of white bagging on patient care, and discusses the best practices in revenue cycle management related to high-cost infusion services. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we discuss one of the ways the pharmacy department at Yale New Haven Hospital has ensured technician engagement across their department. Tune in to learn about how technicians are incorporated into strategic planning for the department, and to hear a first-person technician account about the successes with this strategy.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This presentation focuses on outpatient infectious diseases topics, specifically focusing on HIV prevention. Content experts discuss recent guideline updates, new medications, medication access, and implications in the outpatient setting.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A conversation with the 2021-2022 Chair of the ASHP Section of Ambulatory Care Practitioners (SACP). Listeners will learn about Danny’s pharmacy practice experience, ASHP involvement, and how he’s adapted his SACP leadership term to the continued navigation of the COVID-19 pandemic.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, we chat with Dr. Garrett Schramm, Director of Pharmacy Education and Academic Affairs at Mayo Clinic – Rochester, about the value of community-based pharmacy residencies in training future leaders. Dr. Schramm reviews his organization's pursuit of expanding available pharmacy residencies in community-based practice at Mayo, and the importance of quality training for future practice leaders.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During the COVID-19 pandemic, rapid changes were needed to support fluctuating patient care needs, such as conversion of patient care units to COVID-19 care areas, transformation of level of care (e.g., general floors becoming intensive care units (ICUs)), and modifications to patient populations on units (e.g., pediatric units supporting adult patients). Listeners will learn how automated dispensing cabinets can inventory can be assessed efficiently when patient populations are rapidly changing and explain the importance of including a broad group of health-system stakeholders for planning operations during emergency situations.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.